COVID-19, Immune System and Hi-D FACS: A Review
Emerging Trends in Disease and Health Research Vol. 3,
14 February 2022
,
Page 112-116
https://doi.org/10.9734/bpi/etdhr/v3/3265E
Abstract
Hi-D immunophenotyping of peripheral blood from COVID-19 patients revealed a significant shift in the ratio of immune cells, especially between mature and immature neutrophils associating with severity. Hi-D FACS has also confirmed absolute numbers of lymphocyte subsets were differentially decreased in COVID-19 patients according to clinical severity. Using Hi-D FACS for understanding immune responses in the context of clinical severity is foundation to overcome the lack of effective anti-viral immune response in severely affected COVID-19 patients and can offer prognostic value as biomarker for disease outcome and control.
- COVID 19
- Hi-D FACS
- respiratory syndrome
- neutrophils